The revision of the 2014 European tobacco products directive: an analysis of the tobacco industry's attempts to 'break the health silo'

被引:51
|
作者
Peeters, Silvy [1 ]
Costa, Helia [2 ]
Stuckler, David [2 ,3 ]
McKee, Martin [3 ]
Gilmore, Anna B. [1 ]
机构
[1] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England
[2] Univ Oxford, Dept Sociol, Oxford, England
[3] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England
基金
英国惠康基金; 英国经济与社会研究理事会; 英国医学研究理事会;
关键词
IMPACT ASSESSMENT;
D O I
10.1136/tobaccocontrol-2014-051919
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background The 2014 European Union (EU) Tobacco Products Directive (TPD) was negotiated in a changed policy context, following adoption of the EU's 'Smart Regulation' agenda, which transnational tobacco companies (TTCs) anticipated would increase their influence on health policy, and the WHO Framework Convention on Tobacco Control (FCTC), which sought to reduce it. This study aims to explore the scale and nature of the TTCs' lobby against the EU TPD and evaluate how these developments have affected their ability to exert influence. Methods Analysis of 581 documents obtained through freedom of information requests, 28 leaked Philip Morris International (PMI) documents, 17 TTC documents from the Legacy Library, web content via Google alerts and searches of the EU institutions' websites, plus four stakeholder interviews. Results The lobby was massive. PMI alone employed over 160 lobbyists. Strategies mainly used third parties. Efforts to 'Push' (amend) or 'Delay' the proposal and block ' extreme policy options' were partially successful, with plain packaging and point of sales display ban removed during the 3-year delay in the Commission. The Smart Regulation mechanism contributed to changes and delays, facilitating meetings between TTC representatives (including ex-Commission employees) and senior Commission staff. Contrary to Article 5.3, these meetings were not disclosed. Conclusions During the legislative process, Article 5.3 was not consistently applied by non-health Directorates of the European Commission, while the tools of the Smart Regulation appear to have facilitated TTC access to, and influence on, the 2014 TPD. The use of third parties undermines Article 5.3.
引用
收藏
页码:108 / 117
页数:10
相关论文
共 50 条
  • [1] European Union's tobacco products directive
    McKee, Martin
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [2] Analysis of the tobacco industry's interference in the enforcement of health warnings on tobacco products in Brazil
    Perez, Cristina de Abreu
    da Costa e Silva, Vera Luiza
    Bialous, Stella Aguinaga
    [J]. CADERNOS DE SAUDE PUBLICA, 2017, 33
  • [3] Welcoming the transposition of the European Tobacco Products Directive
    Lozano, Francisco Rodriguez
    [J]. TOBACCO PREVENTION & CESSATION, 2016, 2
  • [4] Court of Justice Upholds the Tobacco Products Directive 2014
    Cathaoir, Katharina O.
    [J]. EUROPEAN JOURNAL OF RISK REGULATION, 2016, 7 (03) : 623 - 628
  • [5] Tobacco and tobacco products test results before and after the implementation of the 2014/40 EU tobacco directive
    Strac, I. Vidic
    Dimitrov, N.
    Damianic, B.
    Gorski, D. Brlek
    Vucic, B.
    Hrnjkas, L.
    [J]. TOXICOLOGY LETTERS, 2019, 314 : S253 - S253
  • [6] Quantifying the influence of the tobacco industry on EU governance: automated content analysis of the EU Tobacco Products Directive
    Costa, Helia
    Gilmore, Anna B.
    Peeters, Silvy
    McKee, Martin
    Stuckler, David
    [J]. TOBACCO CONTROL, 2014, 23 (06) : 473 - 478
  • [7] Information disclosure, smoking and health protection - A critique of the European directive on the labelling of tobacco products
    Cutler, TJ
    Nye, DA
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 1998, 8 (03): : 222 - 226
  • [8] The New EU Tobacco Products Directive and European Fundamental Rights
    Uwer, Dirk
    Rademacher, Moritz
    [J]. EUROPEAN LAW REVIEW, 2015, 40 (01) : 35 - 51
  • [9] Old wine in new bottles: Tobacco industry's submission to European Commission tobacco product directive public consultation
    Hiilamo, Heikki
    Glantz, Stanton A.
    [J]. HEALTH POLICY, 2015, 119 (01) : 57 - 65
  • [10] Assessment of priority tobacco additives per the requirements of the EU Tobacco Products Directive (2014/40/EU)
    Stabbert, R.
    McEwan, M.
    Ashley, M.
    Clarke, A.
    Coburn, S.
    Collard, J.
    Crooks, I.
    Esposito, M.
    Freiesleben, J.
    Ghosh, D.
    Giles, L.
    Jaccard, G.
    Kim, H-K.
    Larroque, S.
    Lindegaard, T.
    Lutz, R.
    Manson, A.
    Martinez, J.
    Miller, J.
    Murphy, J.
    Park, C-H.
    Paschke, T.
    Pollner, G.
    Proctor, C.
    Roemer, E.
    Scharfe, M.
    Sohn, H-O.
    Djoko, D. Tafin
    Vlachos, P.
    Vincze, I.
    Wigotzki, D.
    Yuki, D.
    Simms, L.
    [J]. TOXICOLOGY LETTERS, 2019, 314 : S249 - S249